Cytokinetics's chart data is dated 2026-10-09. Recorded technical signals: RSI rebound. There are 0 published signal records.
Cytokinetics last closed at $62.91 (+1.45%) on 2026-10-09. Signals today: RSI rebound. Listed on Nasdaq. Trailing 12 months PER is -9.2×. Its overall grade ranks 161 of 738 stocks in Healthcare.
About this company
Cytokinetics last closed at $62.91 (+1.45%) on 2026-10-09. Signals today: RSI rebound. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 161/738
Valuation grade A+
Related stocks
- AmgenCompetitor
심근질환 치료제 개발 분야에서 경쟁 가능성이 큰 대형 바이오·제약사
- Bristol Myers SquibbCompetitor
심장질환·희귀질환 등 대형 파이프라인 경쟁사로 자주 비교되는 글로벌 제약사
- NovartisCompetitor
심혈관·희귀질환 치료제 영역에서 경쟁하는 글로벌 제약사
ETFs holding this stock
iShares Russell 2000 Value ETF · Vanguard Russell 2000 Value Index Fund;ETF · iShares Russell 2000 ETF
Details →About Cytokinetics
- What technical signals does Cytokinetics (CYTK) have?
- Cytokinetics current technical signals: RSI rebound.
- Is Cytokinetics a cup-and-handle pattern?
- No. Cytokinetics has no valid Cup signal right now.
- What published figures are available for Cytokinetics?
- Market cap: $7.69B. Trailing 12 months PER: -9.2×. Latest quarter PBR: -47.21×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Cytokinetics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.